Tenoxicam for Intrapartum Analgesia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02549118|
Recruitment Status : Unknown
Verified September 2015 by Hamdy Bakry Mohye Soliman El Kinawy, Ain Shams Maternity Hospital.
Recruitment status was: Not yet recruiting
First Posted : September 15, 2015
Last Update Posted : September 15, 2015
Ain Shams Maternity Hospital
Information provided by (Responsible Party):
Hamdy Bakry Mohye Soliman El Kinawy, Ain Shams Maternity Hospital
The aim of this study is to assess whether tenoxicam is as effective as pethidine for analgesia during the first stage of labor.
|Condition or disease||Intervention/treatment||Phase|
|Analgesia Obstetrical||Drug: Tenoxicam Drug: Pethidine||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Efficacy of Intravenous Tenoxicam as an Analgesic During the First Stage of Labor: A Randomized Controlled Trial|
|Study Start Date :||September 2015|
|Estimated Primary Completion Date :||March 2016|
|Estimated Study Completion Date :||March 2016|
Intravenous administration of tenoxicam, a lyophilisate with 20 mg to be dissolved and diluted in 10 mL of sterile water (single dose), as an analgesic during the first stage of labor, given by a member of the study team.
Active Comparator: Pethidine
Slow intravenous administration of pethidine, 50 mg to be diluted in 10 mL of sterile water (single dose), as an analgesic during the first stage of labor, given by a member of the study team.
Primary Outcome Measures :
- The efficacy of intravenous tenoxicam to supply adequate analgesia as indicated by changes in the pain intensity score using the visual analog scale [ Time Frame: 4 hours ]Assessment is to be done and followed up by the investigator at ½, 1, 2, 3 and 4 hours from drug administration. Scores range from 0 [no pain] to 10 [worst possible pain].
No Contacts or Locations Provided